Kenneth Cartwright

1.9k total citations
13 papers, 1.5k citations indexed

About

Kenneth Cartwright is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Clinical Biochemistry. According to data from OpenAlex, Kenneth Cartwright has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 4 papers in Oncology and 4 papers in Clinical Biochemistry. Recurrent topics in Kenneth Cartwright's work include Advanced Glycation End Products research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). Kenneth Cartwright is often cited by papers focused on Advanced Glycation End Products research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). Kenneth Cartwright collaborates with scholars based in United States, Israel and Canada. Kenneth Cartwright's co-authors include Gary Dukart, S Wolff, Eli A. Friedman, Roger A. Rodby, Anthony Cerami, Zenji Makita, Elliot J. Rayfield, Helen Vlassara, Richard Bucala and Barry I. Freedman and has published in prestigious journals such as Science, Journal of Clinical Oncology and Archives of Biochemistry and Biophysics.

In The Last Decade

Kenneth Cartwright

13 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth Cartwright United States	11	546	395	376	355	233	13	1.5k
Annalisa Iezzi Italy	15	350 0.6×	296 0.7×	168 0.4×	326 0.9×	426 1.8×	19	1.8k
Markus Lassila Finland	21	358 0.7×	412 1.0×	56 0.1×	490 1.4×	331 1.4×	34	1.5k
Yosuke Inagaki Japan	23	1.2k 2.2×	621 1.6×	147 0.4×	846 2.4×	166 0.7×	29	2.5k
Kiyoshi Tamaki Japan	20	153 0.3×	165 0.4×	187 0.5×	989 2.8×	317 1.4×	46	1.9k
Elyce Ozols Australia	13	392 0.7×	256 0.6×	127 0.3×	534 1.5×	131 0.6×	23	1.7k
Daisuke Ogawa Japan	22	259 0.5×	816 2.1×	126 0.3×	793 2.2×	214 0.9×	51	2.2k
Yuko Izuhara Japan	19	468 0.9×	259 0.7×	40 0.1×	310 0.9×	154 0.7×	33	1.4k
M.R. Jirousek United States	10	275 0.5×	219 0.6×	68 0.2×	686 1.9×	112 0.5×	18	1.4k
Vicki Thallas Australia	17	1.4k 2.6×	898 2.3×	84 0.2×	503 1.4×	554 2.4×	20	2.6k
Kerri Thai Canada	33	192 0.4×	839 2.1×	231 0.6×	1.4k 4.0×	790 3.4×	63	3.0k

Countries citing papers authored by Kenneth Cartwright

Since Specialization

Citations

This map shows the geographic impact of Kenneth Cartwright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Cartwright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Cartwright more than expected).

Fields of papers citing papers by Kenneth Cartwright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Cartwright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Cartwright. The network helps show where Kenneth Cartwright may publish in the future.

Co-authorship network of co-authors of Kenneth Cartwright

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Cartwright. A scholar is included among the top collaborators of Kenneth Cartwright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Cartwright. Kenneth Cartwright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Feighner, John P., et al.. (2008). Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients. International Clinical Psychopharmacology. 23(1). 29–35. 3 indexed citations

Bolton, W. Kline, Daniel C. Cattran, Mark E. Williams, et al.. (2004). Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy. American Journal of Nephrology. 24(1). 32–40. 366 indexed citations

Crook, Martin, et al.. (2000). Serum sialic acid in young type-1 diabetic patients. Diabetes Research and Clinical Practice. 47(2). 119–122. 16 indexed citations

Freedman, B. I., Kenneth Cartwright, Raymond P. Bain, et al.. (1999). Design and Baseline Characteristics for the Aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). Controlled Clinical Trials. 20(5). 493–510. 204 indexed citations

Friedman, Eli A., et al.. (1997). Aminoguanidine prolongs survival in azotemic-induced diabetic rats. American Journal of Kidney Diseases. 30(2). 253–259. 9 indexed citations

Makita, Zenji, Helen Vlassara, Elliot J. Rayfield, et al.. (1992). Hemoglobin-AGE: A Circulating Marker of Advanced Glycosylation. Science. 258(5082). 651–653. 218 indexed citations

Arlin, Z, Delvyn C. Case, J. Moore, et al.. (1990). Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.. PubMed. 4(3). 177–83. 145 indexed citations

Henderson, I. Craig, Joseph C. Allegra, Thomas Woodcock, et al.. (1989). Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.. Journal of Clinical Oncology. 7(5). 560–571. 198 indexed citations

Bennett, J M, Hyman B. Muss, James H. Doroshow, et al.. (1988). A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.. Journal of Clinical Oncology. 6(10). 1611–1620. 91 indexed citations

10.

Bennett, John M., Patrick J. Byrne, Ajit Desai, et al.. (1985). A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer. Investigational New Drugs. 3(2). 179–185. 15 indexed citations

11.

Beyer, Robert E., et al.. (1985). Tissue coenzyme Q (ubiquinone) and protein concentrations over the life span of the laboratory rat. Mechanisms of Ageing and Development. 32(2-3). 267–281. 104 indexed citations

12.

Dukart, Gary, et al.. (1985). Mitoxantrone: an overview of safety and toxicity. Investigational New Drugs. 3(2). 123–132. 103 indexed citations

13.

Beyer, Robert E., et al.. (1984). Elevation of tissue coenzyme Q (ubiquinone) and cytochrome c concentrations by endurance exercise in the rat. Archives of Biochemistry and Biophysics. 234(2). 323–329. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact